🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Great heme fact that all ICU docs ought to know: 🩸People on Anti-38 monoclonals (daratumumab, isatuximab) have a false positive type & screen for all minor antigens, potentially delaying transfusion by hours 🏦 Tell the blood bank if a pt has received these mAbs within 6 months

End of a terrific #ASCO2025 Attended some great sessions, met familiar faces and a shoutout to the ASCO TECAG for their incredible events and organisation!

Excited to present our research today at #ASCO25 ASCO! IMG exhibit higher research productivity compared to AMGs - matrix that helps PDs to recruit more IMGs to hemonc fellowship programs! IMG Oncologists Nazli Dizman Fatemeh Ardeshir, MD Ziad Bakouny, MD, MSc Toni Choueiri, MD Ohio State Medical Oncology

🚨 Wow! #ASCO25 ASCO was absolutely massive! 10 NEJM papers published simultaneously 👉 all practice-changing studies ! 🔬✨🧵 See below for these studies 👇@oncoalert

In the latest video in our partnership with Dr. Glaucomflecken, the INSEMA trial investigating axillary surgery in breast cancer is explained. Access the article for free: nej.md/DrG18

Exercizumab?!

Just out. Updated myeloma mSMART guidelines on prevention and management of bispecific antibody associated Cytokine Release Syndrome (CRS) and Neurotoxicity. Yi Lin Mayo Myeloma #ASCO25 Link: msmart.org/mm-treatment-g…

Wrapping up another great ASCO, grateful to have been a part of some impactful projects and having soaked in several practice-changing talks! Looking forward to returning next year, hopefully as an incoming heme/onc fellow! #ASCO25🎗️

📌 Langerhans Cell Histiocytosis (LCH) LCH is a myeloid neoplasm with features of both inflammation & malignancy. 🔬 Clonal CD1a+, CD207+ dendritic cells 🦴 Bone, 🫁 lung, 🧠 pituitary involvement common #MedTwitter

Thrilled to share that our abstract has been accepted for a poster presentation at #SOHO2025! Excited to be returning to Houston and catching up with mentors & colleagues! Nikhil Vojjala, MD deevyaparekh Society of Hematologic Oncology (SOHO)

🚨Proud to share our publication in JCO Oncology Practice 🧵International Medical Graduates (IMGs) are underrepresented in invited faculty roles at #ASCO Annual Meetings, despite their contributions to original research! Toni Choueiri, MD Nazli Dizman Ziad Bakouny, MD, MSc IMG Oncologists gilberto lopes

Evaluation and Treatment of Iron Deficiency for the Practicing Oncologist | JCO Oncology Practice ascopubs.org/doi/10.1200/OP… JCO Oncology Practice ASCO Journal of Clinical Oncology OncoAlert

Hem-Onc Fellows Network Tulsi Jose, MD Noha N. Soror, MD, MSc. 𓂀 Yan Leyfman, MD Avi Harisingani, MD Chalothorn “Sai” Wannaphut, MD Rafik El Beblawy, M.D

😱Challenges in hematology😱 Chronic graft-versus-host disease (GVHD) A short 🧵on what it is and how to treat

In resectable gastric and gastroesophageal junction cancer, adding durvalumab to perioperative chemotherapy improved event-free survival and pathological complete response, with no major increase in high-grade adverse events. Full MATTERHORN phase 3 trial results and Research

Program Director’s Note - Personal Statement Pitfalls A #ProgramDirectorsNote to my Yale IM Traditional Residency Program residents now that fellowship applications are in. My Yale Internal Medicine are great writers, but there are always pitfalls to avoid. open.substack.com/pub/siegelmark…

Excited to have applied for Pulmonology & Critical Care fellowship! 🫁🩺 Grateful for the journey & the mentors who shaped it. SUNY Upstate IM Residency Viren Kaul, MD Wouldn’t be here without my fiancé Avi Harisingani, MD and my parents. AAMC ID: 15140683 #MedTwitter #PulmCrit #fellowshipmatch

Finally. We have European regulatory approval for high risk smoldering myeloma! Await FDA decision. AQUILA trial. NEJM Darzalex (Daratumumab)